IP Library Granted Patent US 12,490,905
Granted Patent B2
US 12,490,905 · App. 16/791,523 · Granted Dec 9, 2025

Systems and methods for predicting tissue viability deficits from physiological, anatomical, and patient characteristics

Inventors: Gilwoo Choi (Mountain View, CA); Michiel Schaap (Mountain View, CA); Charles A. Taylor (Atherton, CA); Leo Grady (Millbrae, CA)
Assignee: Heartflow, Inc.
A61B5/02007A61B5/026A61B5/742G16H50/20G16H50/30G16H50/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,490,905
App. No.
16/791,523
Granted
Dec 9, 2025
Kind
B2
Abstract

Systems and methods are disclosed for using patient-specific anatomical models and physiological parameters to predict viability of a target tissue or vessel to guide diagnosis or treatment of cardiovascular disease. One method includes: receiving a patient-specific vessel model and a patient-specific tissue model of a patient anatomy; receiving one or more patient-specific physiological parameters (e.g. blood flow, anatomical characteristics, etc.) for one or more physiological states; estimating a viability characteristic of the patient-specific tissue or vessel model (e.g., via a trained machine learning algorithm), using the patient-specific physiological parameters; and outputting the viability characteristic to an electronic storage medium or display.

Claims (96)

1 . A computer-implemented method for estimating tissue viability of a patient's tissue, the method comprising:

receiving, via one or more processors, image data derived from one or more images of a patient's anatomy when a patient is at one or more physiological states;

determining, via the one or more processors, one or more image characteristics based on the image data;

generating, via the one or more processors, one or more patient-specific models based on the image data, each being a model of a vessel or tissue of the patient when the patient is at the one or more physiological states;

determining, via the one or more processors, patient-specific values of one or more physiological or anatomical parameters based on the one or more patient-specific models, wherein the one or more physiological or anatomical parameters comprise at least one of anatomical characteristics, blood supply, perfusion territories, patient characteristics, disease burden characteristics, and electromechanical measurements;

determining, via the one or more processors, one or more tissue viability characteristics by inputting the patient-specific values of the one or more physiological or anatomical parameters into a machine learning algorithm to obtain the tissue viability characteristics, wherein the machine learning algorithm is trained by:

receiving tissue viability data and data of one or more physiological or anatomical parameters for a plurality of individuals; and

training the machine learning algorithm by:

using a training set comprising the tissue viability data and the data of one or more physiological or anatomical parameters, wherein the machine learning algorithm is configured to map the one or more physiological or anatomical parameters to tissue viability;

creating a feature vector of the physiological or anatomical parameters; and

associating the feature vector with tissue viability;

outputting, to an electronic storage medium or a display, the tissue viability characteristics based on the feature vector, wherein the tissue viability characteristics include a measure of an extent to which a vessel, tissue, or organ is functional;

modifying the patient-specific values of the one or more physiological or anatomical parameters; and

determining an effect of the modification to the patient-specific values of the one or more physiological or anatomical parameters on the tissue viability characteristics to guide a diagnosis of the patient.

2 . The computer-implemented method of claim 1 , wherein:

the one or more physiological or anatomical parameters include the perfusion territories,

the patient-specific values include a patient tissue perfusion territory estimation, and

the method further comprises:

estimating a blood supply to one or more vessel or tissue areas, using a blood flow simulation in at least one of the one or more patient-specific models;

determining the patient tissue perfusion territory estimation based on the estimated blood supply;

modifying the one or more patient-specific models of the one or more physiological or anatomical parameters;

determining an effect of the modifying the one or more patient-specific models on the tissue viability characteristics;

generating a treatment plan based on the determined effect; and

outputting the treatment plan to the electronic storage medium or the display, the treatment plan being usable for treating ischemia.

3 . The computer-implemented method of claim 2 , wherein the estimated blood supply includes fractional flow reserve, flow magnitude, flow direction, or a combination thereof.

4 . The computer-implemented method of claim 2 , wherein the treatment plan is generated based further on the one or more patient-specific models or the patient-specific values of the one or more physiological or anatomical parameters.

5 . The computer-implemented method of claim 1 , wherein the anatomical characteristics include vessel size, vessel shape, vessel tortuosity, vessel length, vessel thickness, or a combination thereof.

6 . The computer-implemented method of claim 1 , the one or more physiological states include a resting patient state, a hyperemic state, an exercise state, a postprandial state, a gravitational state, an emotional state, a state of hypertension, a medicated state, or a combination thereof.

7 . The computer-implemented method of claim 1 , wherein the one or more image characteristics include, one or more of:

local average intensities,

texture characteristics, and

standard image features.

8 . The computer-implemented method of claim 1 , further including receiving one or more secondary characteristics including patient characteristics, target tissue disease characteristics, electromechanical measurements, or a combination thereof.

9 . The computer-implemented method of claim 1 , further including comparing blood flow characteristics in the tissue or a vessel at different physiological states.

10 . The computer-implemented method of claim 1 , wherein the one or more patient-specific models include:

a coronary vascular model and a model of a myocardium;

a cerebral vascular model and a model of a brain;

a peripheral vascular model and a model of muscle;

a hepatic vascular model and a model of a liver;

a renal vascular model and a model of a kidney;

a visceral vascular model and a model of a bowel; or

a vascular model representing a vessel and a target organ to which blood is supplied by the vessel.

11 . The computer-implemented method of claim 1 , further comprising:

adjusting the patient-specific values of the one or more physiological or anatomical parameters based on the tissue viability characteristics; and

simulating a blood flow characteristic using the tissue viability characteristics and the adjusted patient-specific values.

12 . A system for estimating patient-specific tissue viability, the system comprising:

a data storage device storing instructions for determining characteristics of tissue viability; and

a processor configured to execute the instructions to perform a method comprising:

receiving image data derived from one or more images of a patient's anatomy when a patient is at one or more physiological states;

determining one or more image characteristics based on the image data, the one or more image characteristics including one or more of: local average intensities, texture characteristics, and standard image features;

generating one or more patient-specific models based on the image data, each being a model of a vessel or tissue of the patient when the patient is at the one or more physiological states;

determining patient-specific values of one or more physiological or anatomical parameters based on the one or more patient-specific models, wherein the one or more physiological or anatomical parameters comprise at least one of anatomical characteristics, blood supply, perfusion territories, patient characteristics, disease burden characteristics, and electromechanical measurements;

determining one or more tissue viability characteristics by inputting the patient-specific values of the one or more physiological or anatomical parameters into a machine learning algorithm to obtain the tissue viability characteristics, wherein the machine learning algorithm is trained by:

receiving tissue viability data and data of one or more physiological or anatomical parameters for a plurality of individuals; and

training the machine learning algorithm by:

using a training set comprising the tissue viability data and the data of one or more physiological or anatomical parameters, wherein the machine learning algorithm is configured to map the one or more physiological or anatomical parameters to tissue viability;

creating a feature vector of the physiological or anatomical parameters; and

associating the feature vector with tissue viability;

outputting, to an electronic storage medium or a display, the tissue viability characteristics based on the feature vector, wherein the tissue viability characteristics include a measure of an extent to which a vessel, tissue, or organ is functional;

modifying the patient-specific values of the one or more physiological or anatomical parameters; and

determining an effect of the modification to the patient-specific values of the one or more physiological or anatomical parameters on the tissue viability characteristics to guide a diagnosis of the patient.

13 . The system of claim 12 , wherein:

the one or more physiological or anatomical parameters include the perfusion territories,

the patient-specific values include a patient tissue perfusion territory estimation, and

the method further comprises:

estimating a blood supply to one or more vessel or tissue areas, using a blood flow simulation in at least one of the one or more patient-specific models;

determining the patient tissue perfusion territory estimation based on the estimated blood supply;

modifying the one or more patient-specific models of the one or more physiological or anatomical parameters;

determining an effect of the modifying the one or more patient-specific models on the tissue viability characteristics;

generating a treatment plan based on the determined effect; and

outputting the treatment plan to the electronic storage medium or the display, the treatment plan being usable for treating ischemia.

14 . The system of claim 13 , wherein the one or more physiological states include a resting patient state, a hyperemic state, an exercise state, a postprandial state, a gravitational state, an emotional state, a state of hypertension, a medicated state, or a combination thereof.

15 . The system of claim 13 , wherein the estimated blood supply includes fractional flow reserve, flow magnitude, flow direction, or a combination thereof.

16 . The system of claim 12 , wherein the estimating the tissue viability characteristics includes comparing blood flow characteristics in a tissue or a vessel at different physiological states.

17 . The system of claim 12 , wherein the one or more patient-specific models include:

a coronary vascular model and a myocardium;

a cerebral vascular model and a brain;

a peripheral vascular model and muscle;

a hepatic vascular model and a liver;

a renal vascular model and a kidney;

a visceral vascular model and a bowel; or

a vascular model representing a vessel and a target organ to which blood is supplied by the vessel.

18 . A non-transitory computer readable medium for performing a method on a computer system containing computer-executable programming instructions for estimating a characteristic of tissue viability, the method comprising:

receiving, via one or more processors, image data derived from one or more images of a patient's anatomy when a patient is at one or more physiological states;

determining, via the one or more processors, one or more image characteristics based on the image data;

generating, via the one or more processors, one or more patient-specific models based on the image data, each being a model of a vessel or tissue of the patient when the patient is at the one or more physiological states;

determining, via the one or more processors, patient-specific values of one or more physiological or anatomical parameters based on the one or more patient-specific models, wherein the one or more physiological or anatomical parameters comprise at least one of anatomical characteristics, blood supply, perfusion territories, patient characteristics, disease burden characteristics, and electromechanical measurements;

determining, via the one or more processors, one or more tissue viability characteristics by inputting the patient-specific values of the one or more physiological or anatomical parameters into a machine learning algorithm to obtain the tissue viability characteristics, wherein the machine learning algorithm is trained by:

receiving tissue viability data and data of one or more physiological or anatomical parameters for a plurality of individuals; and

training the machine learning algorithm by:

using a training set comprising the tissue viability data and the data of one or more physiological or anatomical parameters, wherein the machine learning algorithm is configured to map the one or more physiological or anatomical parameters to tissue viability, the tissue viability characteristics including one or more of an estimation of perfusion territories of a target tissue or an estimation of a degree to which the target tissue is functional;

creating a feature vector of the physiological or anatomical parameters; and

associating the feature vector with tissue viability;

outputting, to an electronic storage medium or a display, the tissue viability characteristics based on the feature vector, wherein the tissue viability characteristics include a measure of an extent to which a vessel, tissue, or organ is functional;

modifying the patient-specific values of the one or more physiological or anatomical parameters; and

determining an effect of the modification to the patient-specific values of the one or more physiological or anatomical parameters on the tissue viability characteristics to guide a diagnosis of the patient.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Sep 11, 2025
From: HAYFIN SERVICES LLP
To: HEARTFLOW, INC.
Reel/Frame 072876/0775 →
RELEASE OF SECURITY INTEREST Recorded Jun 21, 2024
From: HAYFIN SERVICES LLP
To: HEARTFLOW, INC.
Reel/Frame 067801/0032 →
SECURITY INTEREST Recorded Jun 18, 2024
From: HEARTFLOW, INC.
To: HAYFIN SERVICES LLP
Reel/Frame 067775/0966 →
SECURITY INTEREST Recorded Jan 20, 2021
From: HEARTFLOW, INC.
To: HAYFIN SERVICES LLP
Reel/Frame 055037/0890 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2020
From: CHOI, GILWOO; SCHAAP, MICHIEL; TAYLOR, CHARLES A.; GRADY, LEO
To: HEARTFLOW, INC.
Reel/Frame 051841/0594 →
Continuity (3)
Continuation 15088969 · Apr 1, 2016
Provisional Application 62142172 · Apr 2, 2015
Related Publication 20200178815A1 · Jun 11, 2020
References Cited (7)
US 7693315B2 · Krishnan et al. · 2010 [cited by applicant]
US 8315812B2 · Taylor · 2012 [cited by applicant]
US 20150038860A1 · Fonte et al. · 2015 [cited by applicant]
Wu et al., “Noninvasive Imaging of Myocardial Viability: Current Techniques and Future Developments,” Circ. Res., 2003, vol. 93, pp. 1146-1158. [cited by applicant]
O'Donnell et al., International Journal of Computer Vision (2006) vol. 70: 165-178. [cited by applicant]
Schinkel et al., Journal of Nuclear Medicine (2007) vol. 48:1135-1146. [cited by applicant]
Mendoza, D. et al., “Evaluation of myocardial viability by multidetector CT,” Journal of Cardiovascular Computed Tomography, 2009, vol. 3, Suppl. 1:, pp. S2-S12. [cited by applicant]
Cited By (1)
US 12,714,382